Arotinolol
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers.[1] It also acts as a β3 receptor agonist.[2] A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".[3]
Medical uses
It is used in the treatment of high blood pressure[4] and essential tremor.[5][6] Recommended dosage is 10 to 30 mg per day.Script error: No such module "Unsubst".
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".Template:Closed access
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".Template:Open access
- ↑ Script error: No such module "Citation/CS1".Template:Open access
- ↑ Script error: No such module "Citation/CS1".Template:Closed access
- ↑ Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".
External links
- Template:In lang Almarl Full Prescribing Information. Revised November 2009 Sumitomo Dainippon Pharma Co., Ltd.
- Template:In lang Official Sumitomo Dainippon Pharma Website Template:Webarchive
- Script error: No such module "citation/CS1".
Script error: No such module "Navbox". Template:Adrenergic receptor modulators